AU3662593A - Pulmonary surfactant protein fragments - Google Patents

Pulmonary surfactant protein fragments

Info

Publication number
AU3662593A
AU3662593A AU36625/93A AU3662593A AU3662593A AU 3662593 A AU3662593 A AU 3662593A AU 36625/93 A AU36625/93 A AU 36625/93A AU 3662593 A AU3662593 A AU 3662593A AU 3662593 A AU3662593 A AU 3662593A
Authority
AU
Australia
Prior art keywords
pulmonary surfactant
surfactant protein
protein fragments
fragments
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36625/93A
Other languages
English (en)
Inventor
Darryl Robin Absolom
Constance Hope Baxter
Madhup Krishna Dhaon
Edwin Orville Lundell
Virender Kumar Sarin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU3662593A publication Critical patent/AU3662593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU36625/93A 1992-04-10 1993-02-09 Pulmonary surfactant protein fragments Abandoned AU3662593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86691692A 1992-04-10 1992-04-10
US866916 1992-04-10

Publications (1)

Publication Number Publication Date
AU3662593A true AU3662593A (en) 1993-11-18

Family

ID=25348718

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36625/93A Abandoned AU3662593A (en) 1992-04-10 1993-02-09 Pulmonary surfactant protein fragments

Country Status (8)

Country Link
US (2) US5547937A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0635028B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE231522T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3662593A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69332654T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2192190T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW240170B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1993021221A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020307A (en) * 1997-04-25 2000-02-01 Ony, Inc. Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C
US6013764A (en) * 1996-07-17 2000-01-11 Ortho Pharmaceutical Corp. Liquid phase peptide synthesis of KL-4 pulmonary surfactant
US5958902A (en) 1997-04-16 1999-09-28 Wisconsin Alumni Research Foundation Method and composition for treating sleep apnea
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US7541331B2 (en) 2005-01-06 2009-06-02 Discovery Laboratories, Inc. Surfactant treatment regimen
CA2606688A1 (en) * 2005-05-03 2006-11-09 Ross Allen Ridsdale Phospholipid formulations and uses thereof in lung disease detection and treatment
PT103484B (pt) * 2006-05-19 2008-03-31 Univ Do Minho Formulação com domínios de ligação hidrófobos e domínios de ligação a hidratos de carbono para aplicações cosméticas nomeadamente para tratamento de fibras queratinosas como o cabelo.
MX2009003002A (es) * 2006-09-19 2009-06-01 Discovery Lab Inc Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
KR20100020511A (ko) * 2007-06-05 2010-02-22 파카 풀머네리 파마슈티칼즈, 인크. 폐로의 약물 전달을 위한 조성물, 이의 용도
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234475A (en) * 1975-08-15 1980-11-18 The Gillette Company Reacting protein with organic acid
US5055553A (en) * 1985-09-26 1991-10-08 Genetics Institute Inc. Low molecular weight pulmonary surfactant proteins
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
HU217612B (hu) * 1991-05-23 2000-03-28 Merrel Dow Pharmaceuticals Inc. Eljárás elasztáz és katepszin G inhibitor hatású peptidek előállítására

Also Published As

Publication number Publication date
DE69332654T2 (de) 2003-09-25
EP0635028A4 (en) 1995-11-22
US5547937A (en) 1996-08-20
EP0635028A1 (en) 1995-01-25
TW240170B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-02-11
WO1993021221A1 (en) 1993-10-28
ATE231522T1 (de) 2003-02-15
US5753621A (en) 1998-05-19
DE69332654D1 (de) 2003-02-27
ES2192190T3 (es) 2003-10-01
EP0635028B1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
AU3662593A (en) Pulmonary surfactant protein fragments
GB2288732B (en) Pharmaceutical compositions
AU3173297A (en) Exendin analogues, processes for their preparation and medicaments containing them
NO933798D0 (no) Keramiske slipekorn, fremgangsmaate for fremstilling av slike, samt slipeprodukter fremstilt fra slike
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HUT63868A (en) Grain for grinding composition, grinding composition and process for producing the grain
AU7498394A (en) Arrangement for surface treatment, especially the cleaning of the surfaces of large objects
MY114140A (en) Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy.
AU2046288A (en) Agglomerated abrasive material, compositions comprising same, and processes for its manufacture
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
CA2123315A1 (en) Therapeutic agents which are antagonists or partial agonists of human interleukin 4
AU640238B2 (en) Process for the preparation of dialkyl pyridine-2,3-dicarboxylates and derivatives thereof from dialkyl dichlorosucciante
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU7842191A (en) Process for the preparation of dialkyl pyridine-2,3,-dicarboxylates and derivatives thereof from dialakyl dichloromaleate
CA2275379A1 (en) Use of pramipexole in the treatment of restless legs syndrome
HUT41002A (en) Process for preparing anticonvulsives
GR3019015T3 (en) Process for the preparation of 1,1,1,2-tetra-fluoroethane.
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
IL125439A0 (en) Process for the production of powdered pulmonary surfactant preparations
AU3737289A (en) Agent for treating pancreatitis or the like
EP0562575A3 (en) N-substituted-3-(substited hydrazino)-benzenesulfonamide derivatives, prepation process thereof, and herbicidal compositions
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
ZA91752B (en) Process for the enzymatic cleavage or recombinant proteins using iga proteases
AU646941B2 (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process